- Home
- CRT vs TELA Comparison
CRT vs TELA Comparison
Compare CRT & TELA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRT
- TELA
- Stock Information
- Founded
- CRT 1991
- TELA 2012
- Country
- CRT United States
- TELA United States
- Employees
- CRT N/A
- TELA N/A
- Industry
- CRT Oil & Gas Production
- TELA Medical/Dental Instruments
- Sector
- CRT Energy
- TELA Health Care
- Exchange
- CRT Nasdaq
- TELA Nasdaq
- Market Cap
- CRT 60.7M
- TELA 61.8M
- IPO Year
- CRT 1992
- TELA 2019
- Fundamental
- Price
- CRT $9.90
- TELA $2.93
- Analyst Decision
- CRT
- TELA Strong Buy
- Analyst Count
- CRT 0
- TELA 4
- Target Price
- CRT N/A
- TELA $9.25
- AVG Volume (30 Days)
- CRT 29.6K
- TELA 199.9K
- Earning Date
- CRT 01-01-0001
- TELA 11-07-2024
- Dividend Yield
- CRT 10.32%
- TELA N/A
- EPS Growth
- CRT N/A
- TELA N/A
- EPS
- CRT 1.13
- TELA N/A
- Revenue
- CRT $7,711,133.00
- TELA $68,649,000.00
- Revenue This Year
- CRT N/A
- TELA $30.39
- Revenue Next Year
- CRT N/A
- TELA $25.51
- P/E Ratio
- CRT $8.68
- TELA N/A
- Revenue Growth
- CRT N/A
- TELA 29.34
- 52 Week Low
- CRT $8.88
- TELA $2.30
- 52 Week High
- CRT $18.49
- TELA $7.84
- Technical
- Relative Strength Index (RSI)
- CRT 44.08
- TELA 47.06
- Support Level
- CRT $9.27
- TELA $2.80
- Resistance Level
- CRT $9.88
- TELA $3.00
- Average True Range (ATR)
- CRT 0.32
- TELA 0.18
- MACD
- CRT -0.03
- TELA -0.01
- Stochastic Oscillator
- CRT 50.05
- TELA 32.95
About CRT Cross Timbers Royalty Trust
Cross Timbers Royalty Trust is a United States based trust. Its principal asset is the net profits interests. The net profits interests are derived from producing royalty, overriding royalty interests, and working interests properties. The underlying properties of the trust include producing properties in Texas, Oklahoma, and New Mexico.
About TELA TELA Bio Inc.
TELA Bio Inc is a United States-based medical technology company. The company is involved in developing and marketing of tissue reinforcement materials to address unmet needs in soft tissue reconstruction. Its reinforced tissue matrices called OviTex improve the clinical outcomes and reduce costs of care in hernia repair, abdominal wall reconstruction and plastic and reconstructive surgery. The company's second portfolio of products, the OviTex PRS Reinforced Tissue Matrix, addresses unmet needs in plastic and reconstructive surgery.